These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15071617)

  • 1. Migraine medication attributes are important for patient compliance.
    Massiou H
    Drugs Today (Barc); 2003; 39 Suppl D():25-9. PubMed ID: 15071617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment.
    Gallagher RM; Kunkel R
    Headache; 2003 Jan; 43(1):36-43. PubMed ID: 12864756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient treatment preferences and the 5-HT1B/1D agonists.
    Ryan RE
    Arch Intern Med; 2001 Nov; 161(21):2545-53. PubMed ID: 11718585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to acute migraine medication: what does it mean, why does it matter?
    Katić BJ; Krause SJ; Tepper SJ; Hu HX; Bigal ME
    Headache; 2010 Jan; 50(1):117-29. PubMed ID: 19817884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' preference for migraine preventive therapy.
    Peres MF; Silberstein S; Moreira F; Corchs F; Vieira DS; Abraham N; Gebeline-Myers C
    Headache; 2007 Apr; 47(4):540-5. PubMed ID: 17445103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical approach to migraine headache.
    Mendizabal JE
    Compr Ther; 2000; 26(4):263-8. PubMed ID: 11126097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The doctor and the migraine patient: improving compliance.
    MacGregor EA
    Neurology; 1997 Mar; 48(3 Suppl 3):S16-20. PubMed ID: 9071265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.
    Massiou H; Pradalier A; Donnet A; Lanteri-Minet M; Allaf B
    Eur Neurol; 2006; 55(4):198-203. PubMed ID: 16772716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of migraines and migraine variants.
    Harmon TP
    Prim Care; 2015 Jun; 42(2):233-41. PubMed ID: 25979584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing relief from headache pain. Current options for acute and prophylactic therapy.
    Ward TN
    Postgrad Med; 2000 Sep; 108(3):121-8; quiz 26. PubMed ID: 11004939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitions, emotions, and behavior of patients with migraine when taking medication during an attack.
    Passchier J; Mourik J; Brienen JA; Hunfeld JA
    Headache; 1998 Jun; 38(6):458-64. PubMed ID: 9664751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing migraine: a patient's perspective.
    Sims C
    Headache; 2001; 41(10):948-9. PubMed ID: 11903520
    [No Abstract]   [Full Text] [Related]  

  • 19. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
    Pascual J; Muñoz R; Leira R
    Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
    Malik SN; Hopkins M; Young WB; Silberstein SD
    Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.